LUMEN TECHNOLOGIES INC (1CYTH.MI) Stock Fundamental Analysis
Europe - BIT:1CYTH - US5502411037 - Common Stock
9.503 EUR
+0.41 (+4.52%)
We assign a fundamental rating of 2 out of 10 to 1CYTH. 1CYTH was compared to 29 industry peers in the Diversified Telecommunication Services industry. 1CYTH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1CYTH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year 1CYTH has reported negative net income.
1CYTH had a positive operating cash flow in the past year.
1CYTH had negative earnings in 4 of the past 5 years.
In the past 5 years 1CYTH always reported a positive cash flow from operatings.
1.2 Ratios
1CYTH has a worse Return On Assets (-3.58%) than 72.41% of its industry peers.
1CYTH has a Return On Invested Capital of 1.05%. This is in the lower half of the industry: 1CYTH underperforms 75.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1CYTH is below the industry average of 7.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.58% | ||
| ROE | N/A | ||
| ROIC | 1.05% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
1.3 Margins
1CYTH has a worse Operating Margin (3.21%) than 68.97% of its industry peers.
In the last couple of years the Operating Margin of 1CYTH has declined.
Looking at the Gross Margin, with a value of 47.68%, 1CYTH is in line with its industry, outperforming 48.28% of the companies in the same industry.
1CYTH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.21% | ||
| PM (TTM) | N/A | ||
| GM | 47.68% |
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
2. Health
2.1 Basic Checks
1CYTH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, 1CYTH has more shares outstanding
The number of shares outstanding for 1CYTH has been reduced compared to 5 years ago.
Compared to 1 year ago, 1CYTH has an improved debt to assets ratio.
2.2 Solvency
1CYTH has an Altman-Z score of -0.03. This is a bad value and indicates that 1CYTH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.03, 1CYTH is not doing good in the industry: 79.31% of the companies in the same industry are doing better.
The Debt to FCF ratio of 1CYTH is 19.08, which is on the high side as it means it would take 1CYTH, 19.08 years of fcf income to pay off all of its debts.
1CYTH has a Debt to FCF ratio of 19.08. This is in the lower half of the industry: 1CYTH underperforms 68.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 19.08 | ||
| Altman-Z | -0.03 |
ROIC/WACC0.17
WACC6.26%
2.3 Liquidity
1CYTH has a Current Ratio of 2.13. This indicates that 1CYTH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.13, 1CYTH belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
A Quick Ratio of 2.10 indicates that 1CYTH has no problem at all paying its short term obligations.
The Quick ratio of 1CYTH (2.10) is better than 96.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.1 |
3. Growth
3.1 Past
The earnings per share for 1CYTH have decreased strongly by -11.11% in the last year.
Looking at the last year, 1CYTH shows a decrease in Revenue. The Revenue has decreased by -6.50% in the last year.
The Revenue has been decreasing by -9.39% on average over the past years.
EPS 1Y (TTM)-11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.92%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-5.39%
3.2 Future
1CYTH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.71% yearly.
The Revenue is expected to decrease by -2.87% on average over the next years.
EPS Next Y-223.49%
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
EPS Next 5Y5.71%
Revenue Next Year-4.81%
Revenue Next 2Y-5.15%
Revenue Next 3Y-4.24%
Revenue Next 5Y-2.87%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for 1CYTH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1CYTH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
1CYTH's Enterprise Value to EBITDA ratio is in line with the industry average.
62.07% of the companies in the same industry are more expensive than 1CYTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.01 | ||
| EV/EBITDA | 8.42 |
4.3 Compensation for Growth
1CYTH's earnings are expected to decrease with -16.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
5. Dividend
5.1 Amount
1CYTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1CYTH (10/30/2025, 7:00:00 PM)
9.503
+0.41 (+4.52%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners71.63%
Inst Owner ChangeN/A
Ins Owners7.81%
Ins Owner ChangeN/A
Market Cap9.75B
Revenue(TTM)12.82B
Net Income(TTM)-1179000000
Analysts71
Price Target4.64 (-51.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-68.79%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.47%
Min EPS beat(2)52.11%
Max EPS beat(2)88.84%
EPS beat(4)3
Avg EPS beat(4)91.86%
Min EPS beat(4)-45.54%
Max EPS beat(4)272.03%
EPS beat(8)4
Avg EPS beat(8)-65.72%
EPS beat(12)7
Avg EPS beat(12)-22.95%
EPS beat(16)9
Avg EPS beat(16)-14.81%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)1.96%
Revenue beat(8)1
Avg Revenue beat(8)-1.16%
Revenue beat(12)1
Avg Revenue beat(12)-1.38%
Revenue beat(16)1
Avg Revenue beat(16)-1.51%
PT rev (1m)6.11%
PT rev (3m)7.88%
EPS NQ rev (1m)-1.09%
EPS NQ rev (3m)19.7%
EPS NY rev (1m)-3.19%
EPS NY rev (3m)33%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.88 | ||
| P/FCF | 12.01 | ||
| P/OCF | 2.57 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.42 |
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)0.79
FCFY8.33%
OCF(TTM)3.7
OCFY38.93%
SpS10.82
BVpS-0.5
TBVpS-4.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.58% | ||
| ROE | N/A | ||
| ROCE | 1.4% | ||
| ROIC | 1.05% | ||
| ROICexc | 1.11% | ||
| ROICexgc | 1.33% | ||
| OM | 3.21% | ||
| PM (TTM) | N/A | ||
| GM | 47.68% | ||
| FCFM | 7.31% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
ROICexc(3y)3.6%
ROICexc(5y)4.47%
ROICexgc(3y)6.03%
ROICexgc(5y)8.09%
ROCE(3y)4.57%
ROCE(5y)5.8%
ROICexgc growth 3Y-47.53%
ROICexgc growth 5Y-31.85%
ROICexc growth 3Y-41.43%
ROICexc growth 5Y-24.11%
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
F-Score5
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 19.08 | ||
| Debt/EBITDA | 5.36 | ||
| Cap/Depr | 120.27% | ||
| Cap/Sales | 26.88% | ||
| Interest Coverage | 0.31 | ||
| Cash Conversion | 133.77% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.1 | ||
| Altman-Z | -0.03 |
F-Score5
WACC6.26%
ROIC/WACC0.17
Cap/Depr(3y)102.09%
Cap/Depr(5y)91.52%
Cap/Sales(3y)21.07%
Cap/Sales(5y)19.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.92%
EPS Next Y-223.49%
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
EPS Next 5Y5.71%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-5.39%
Revenue Next Year-4.81%
Revenue Next 2Y-5.15%
Revenue Next 3Y-4.24%
Revenue Next 5Y-2.87%
EBIT growth 1Y-28.35%
EBIT growth 3Y-51.9%
EBIT growth 5Y-33.9%
EBIT Next Year399.42%
EBIT Next 3Y75.15%
EBIT Next 5Y39.88%
FCF growth 1Y243.21%
FCF growth 3Y-32.61%
FCF growth 5Y-18.43%
OCF growth 1Y78.32%
OCF growth 3Y-12.65%
OCF growth 5Y-8.29%
LUMEN TECHNOLOGIES INC / 1CYTH.MI FAQ
What is the ChartMill fundamental rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
ChartMill assigns a fundamental rating of 2 / 10 to 1CYTH.MI.
What is the valuation status of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to LUMEN TECHNOLOGIES INC (1CYTH.MI). This can be considered as Overvalued.
What is the profitability of 1CYTH stock?
LUMEN TECHNOLOGIES INC (1CYTH.MI) has a profitability rating of 1 / 10.
What is the financial health of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
The financial health rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) is 4 / 10.
Can you provide the expected EPS growth for 1CYTH stock?
The Earnings per Share (EPS) of LUMEN TECHNOLOGIES INC (1CYTH.MI) is expected to decline by -223.49% in the next year.